FDA | Pharmatell

Eyes on Pharma

Check-out What Intel Caught our Eye

Jul 175 min read

Eyes On the Competition

his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...

Jun 54 min read

Eyes on Recent News from BioPharma + a 2023 Top WW 2023 List

This week we've had eyes on BioPharma happenings plus a 2023 Top Selling Drugs list.

Mar 244 min read

Eyes on Current Events - Deals, Approvals & Operations

We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.

Mar 113 min read

Eyes On Healthcare Headlines

Some of the highlights include AI medical advancements, strategic industry movements, regulatory updates, & challenges within the pharma ...

Jul 10, 20222 min read

Pharma CI Europe Conference +FDA Updates + Clinical Data Readouts

The PharmaTell Team has had Eyes On — The Pharma CI Europe Conference, US FDA Regulatory Updates. Plus 2H22 Clinical Data Readouts.

May 15, 20222 min read

Product Approvals, Delays & Disappointments

This was a busy week for Healthcare with 1Q22 Results. The PharmaTell Team had eyes on some of the US FDA decisions + Roche's SKYSCRAPER-01

Mar 27, 20222 min read

FDA Approvals, Transcripts & Conferences

This week, the team has been looking at congress planners, earnings call transcripts, and the US FDA.

Mar 20, 20222 min read

Gene Therapy Guidance

This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.